Fluorescence correlation spectroscopy reveals topological segregation of the two tumor necrosis factor membrane receptors  by Gerken, Margarita et al.
Biochimica et Biophysica Acta 1798 (2010) 1081–1089
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamemFluorescence correlation spectroscopy reveals topological segregation of the two
tumor necrosis factor membrane receptors
Margarita Gerken a,1, Anja Krippner-Heidenreich b,1,2, Steffen Steinert a, Sylvia Willi b, Felix Neugart a,
Andrea Zappe a, Jörg Wrachtrup a, Carsten Tietz a, Peter Scheurich b,⁎
a Institute of Physics, University of Stuttgart, Pfaffenwaldring 57, D-70550 Stuttgart, Germany
b Institute of Cell Biology and Immunology, University of Stuttgart, Allmandring 31, D-70569 Stuttgart, Germany⁎ Corresponding author. Fax: +49 711 685 67484.
E-mail address: peter.scheurich@izi.uni-stuttgart.de
1 M.G. and A.K.-H. contributed equally to this work.
2 Current address: Newcastle University, Institute o
Catherine Cookson Building, Framlington Place, Newcas
0005-2736/$ – see front matter © 2010 Elsevier B.V. A
doi:10.1016/j.bbamem.2010.02.021a b s t r a c ta r t i c l e i n f oArticle history:
Received 9 September 2009
Received in revised form 16 February 2010
Accepted 17 February 2010
Available online 23 February 2010
Keywords:
Tumor necrosis factor (TNF)
Plasma membrane receptor
Receptor complex
Fluorescence correlation spectroscopy
TNF receptor associated factor (TRAF)
MicrodomainsThe proinﬂammatory cytokine tumor necrosis factor (TNF) binds two distinct plasma membrane receptors,
TNFR1 and TNFR2. We have produced different receptor mutants fused with enhanced green ﬂuorescent
protein to study their membrane dynamics by ﬂuorescence correlation spectroscopy (FCS). TNFR1 mutants
show diffusion constants of approximately 1.2×10−9 cm2/s and a broad distribution of diffusion times,
which is hardly affected by ligand binding. However, cholesterol depletion enhances their diffusion,
suggesting a constitutive afﬁnity to cholesterol rich membrane microdomains. In contrast, TNFR2 and
mutants thereof diffuse rather fast (D
–
=3.1×10−9 cm2/s) with a marked reduction after 30 min of TNF
treatment (D
–
=0.9×10−9 cm2/s). This reduction cannot be explained by the formation of higher ordered
receptor clusters, since the ﬂuorescence intensity of TNF treated receptors indicate the presence of a few
receptor molecules per complex only. Together, these data point to a topological segregation of the two TNF
receptors in different microcompartments of the plasma membrane independent of the cytoplasmic
signaling domains of the receptors.(P. Scheurich).
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The proinﬂammatory cytokine tumor necrosis factor (TNF) is a
product of activated immune cells, such as macrophages and T
lymphocytes, and acts as a general activator of the innate immune
system. TNF is bioactive as a non-covalently linked homotrimer. TNF is
initially expressed on the cell surface of the respective producer cell as
a type II transmembrane protein, which can be proteolytically
processed to form the soluble cytokine. Both TNF forms bind two
cell surface receptors, TNFR1 and TNFR2, which are members of the
TNF receptor superfamily [1]. As indicated by the crystal structure of
lymphotoxin alpha complexed with the extracellular domain of
TNFR1 [2] TNF binds up to three receptors per TNF homotrimer. For
initiation of strong signals, however, larger ligand/receptor clusters
are likely to be formed [3,4]. TNFR1 contains a so-called death domain
(DD) within its cytoplasmic part that recruits DD-containing adaptor
molecules after TNF binding. Subsequently other adaptor proteins are
recruited/activated, leading to the activation of e.g. the transcription
factor NF-κB (nuclear factor kappa B) but also to the initiation ofapoptosis [5]. TNFR1 may be associated with caveolae and/or other
microdomains and this interaction might guide whether primarily
gene inductory (antiapoptotic) or proapoptotic signaling is initiated
[6–13]. TNFR2 does not carry a DD and belongs to a subgroup of the
TNF receptor family members that directly interact with TRAF (TNF
receptor associated factor) molecules, leading also to the activation of
NF-κB [14]. Particularly TRAF2 is an important component of the
receptor signaling complex, representing one of the key elements in
TNFR1 and -R2 crosstalk [15].
Importantly, both TNF receptors bind both forms of TNF, but TNFR2
can be fully activated only by membrane bound TNF (memTNF),
rather than the soluble cytokine [16]. The probable reason is the
higher demand of TNFR2 for ligand-mediated crosslinking to allow
signaling cluster formation, which is independent of the signaling
pathways initiated by the two TNF receptors [4,17].
Fluorescence correlation spectroscopy (FCS) and single molecule
tracking provide unique tools to investigate different aspects of intra-
and intercellular communication in vivo in real time. FCS has been
used to study ligand–receptor binding in a variety of systems [18–23].
In addition, ligand induced receptor oligomerization, representing an
important process in the early stages of signal initiation, has been
analyzed via single particle tracking methods [24,25]. Recently, FCS
and single molecule tracking have contributed considerably to our
understanding of the physicochemical behavior of membrane com-
positions and their inﬂuence on receptor partitioning in different
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believed to function as important signaling platforms for numerous
receptors [29–31]. Importantly, due to the high sensitivity of FCS, this
method does not require any overexpression of target proteins in
cells. Studies performed with this method should therefore more
closely reﬂect physiological conditions than most data revealed from
regular ﬂuorescence microscopy.
In the present study we demonstrate that TNFR1 and TNFR2 show
different dynamics in the plasma membrane independent on their
respective intracellular signaling parts. TNFR2, as well as a TNFR2
mutant devoid of its functional intracellular signaling domain, diffuse
with a diffusion constant typical for a single membrane-spanning
domain. In contrast, the median diffusion rate of TNFR1 mutants is
much slower and spread over a broader range. Addition of TNF reveals
no observable changes in the diffusion of TNFR1 mutants but strongly
diminishes TNFR2 diffusion. Importantly, cholesterol depletion affects
TNF/TNFR1mutant complex diffusion, but not that of activated TNFR2
complexes pointing to a topological segregation of the membrane
receptors in different membrane compartments of distinct nature.2. Materials and methods
2.1. Cell lines, plasmids and reagents
The human cervix carcinoma cell line HeLa and immortalizedmouse
ﬁbroblasts (MF) from TNFR1/TNFR2 double knockout mice [4] were
grown in RPMI 1640 medium supplemented with 5% (v/v) heat
inactivated fetal calf serumand2 mML-glutamine. Recombinanthuman
soluble TNF (sTNF) (2×107 U/mg) was provided by Knoll AG
(Ludwigshafen, Germany) and the TNFR2 selective TNF mutant
CysTNF143N/145R (CysTNFR2) has been generated in E. coli andpuriﬁed
to homogeneity using a HiTrap column (Pharmacia) [17]. LPS was
removed using Endo Trap blue 10 (Profos AG) and veriﬁed by Limulus
test (Cambrex). The expression plasmids pTNFR1-YFP, pTNFR1Δ42-
EGFP (carrying a deletion of 126 bp in the TNFR1 3′ terminal coding
region [aa 414–455] with abrogated cytotoxic activity most likely
caused at the level of TRADD binding [32]), pTNFR2-EGFP and pTRAF2-
EGFP were obtained from H. Wajant (University of Würzburg,
Würzburg, Germany) [33]. The expression vectors pTNFR1ΔSD-EGFP
and pTNFR2ΔSD-EGFP were generated by KpnI and SacI restriction
endonuclease digestion of pBSTNFR1+KpnI and pBSTNFR2+KpnI [4].
The same restriction endonucleases were used for pEGFP-N2
(TNFR1ΔSD) and pEGFP-N1 (TNFR2ΔSD) (Clontech, Heidelberg,
Germany) followed by in frame ligation resulting in TNFR deleted in
the C-terminal cytoplasmic 220 amino acids (aa) in case of TNFR1ΔSD
and 160 aa of TNFR2ΔSD. TNFR1ΔSD has one residual cytoplasmic aa
juxtamembrane left andwas fused toEGFPby a short vector based linker
sequence spanning another 12 aa. TNFR2ΔSD contains 14 residual
cytoplasmic aa juxtamembraneof TNFR2 and contains a linker sequence
of 9 aa. Methyl-β-cyclodextrin (MβCD) and Annexin V-FITC were
purchased from Sigma-Aldrich (Taufkirchen, Germany).2.2. Transient transfections
2.5×105 HeLa cells, HeLa cells stably expressing TNFR2 (HeLa80) or
MFwere seeded into a35 mmglass bottomdish (MatTekCorp., Ashland,
USA). The next day cells were transiently transfected with pTNFR1Δ42-
EGFP, pTNFR2-EGFP, pTNFR1ΔSD -EGFP or pTNFR2ΔSD -EGFP expres-
sion plasmids using Effectene (Qiagen AG, Hilden, Germany). Expression
plasmids (5–10 ng)weremixedwithnon-codingplasmids (pBS SK+) to
a total amount of 750 ng. Mouse ﬁbroblasts were transfected with
Lipofectamine2000 (Invitrogen) using 500 ng of the respective expres-
sion plasmids and 3.5 μg pBS SK+. Transfections were performed
according to manufacturer's recommendations.2.3. Fluorescence correlation spectroscopy (FCS) measurements —
experimental setup
FCS studies were performed using a home-built confocal setup
which consists of a modiﬁed inverse microscope (Olympus IX-70)
with a high numerical aperture objective (Olympus UPlanApo 60×/
NA1.2, water immersion). The sample was mounted on a 3D piezo
scanner (P517, Physik Instrumente) with a scanning range of
200×200×20 μm3. The sample was excited with laser light using a
quartz beam splitter and one of the optical side ports of the
microscope. The ﬂuorescence of the sample was detected with an
actively quenched avalanche photo diode (Perkin Elmer, SPCM-AQR
14). Bandpass ﬁlters adapted to the samples emission properties were
installed between the pinhole and the APD. Data collection and
visualization were done using custom software. Fluorescence auto-
correlation was recorded simultaneously with a hardware correlator
(ALV-5000) using acquisition times of 1–3 min. The ﬁt of the
autocorrelation provides information of the diffusion constant (D)
and of the concentration by its ﬁtting parameter t (diffusion time) and
G(0) (the amplitude). The data was ﬁtted according to
G τð Þ =
NGFP 1 +
τ
τD;GFP
 −1
+ NTNFR 1 +
τ
τD;TNFR
 −1
NGFP + NTNFRð Þ2
where NGFP and NTNFR are the respective mean numbers of free GFP
and ﬂuorescent receptors in the focal volume and τD,GFP and τD,TNFR
are the corresponding diffusion times.
Transient transfected cells were washed three times with PBS
(0.7% (w/v) NaCl, 20 mM Na3P04, pH 7.4) and cells were kept in a
phenol red-free cell culture medium throughout the FCS measure-
ments. Cells were treated with sTNF and TNFR2-selective CysTNFR2
(100 ng/ml each), respectively, where indicated. Cholesterol deple-
tion experiments were performed by incubating cells for 30 min in
PBSwith 1 mMMβCD prior to FCS and before the addition of sTNF and
CysTNFR2 (100 ng/ml each), respectively. Measurements were carried
out no longer than 2 h at RT. Each data set was recorded at different
positions of the plasma membrane in more than 25 cells. TRAF2-EGFP
was measured under the same conditions as described for the TNF
receptor and subsequently analyzed using a two-component ﬁt as
discussed above.
Viability tests: 2.5×105 HeLa cells were seeded into a 35 mm dish.
The next day cells were incubated in RPMI1640 culture medium with
5% FCS for 2 h at room temperature and annexin V-FITC/propidium
iodide staining was performed according to the manufacturer's
recommendations. Stained cells were analyzed by ﬂow cytometry.
2.4. Simulation
The conditions for the Monte Carlo simulations were adjusted to
the conditions used in the experiments. A model comparable to the
model described in Wohland et al. [34] with a slight adaptation was
used. To simulate the ﬂuorescence intensity traces we consider
membrane bound particles representing the EGFP labeled TNF
receptors and free diffusing particles representing the free EGFP
within the cytoplasm. As simulation volume a square cuboid with a
base area of ∼3×3 μm² representing the membrane was chosen. The
height of the cuboid was ∼10 μm. Free particles could diffuse in the
total volume of the cuboid with reﬂecting boundary conditions at the
base and periodic boundary conditions for all other areas. Membrane
bound particles was constraint to the base area using periodic bound-
ary conditions. Number of particles was 4 (cytosol) and 3 (mem-
brane), respectively. The excitation intensity was calculated by a 3D
Gaussian functionwith a lateral width of 300 nm and an axial width of
1 μm. The center of the Gaussian was placed at the center of the base
Fig. 1.Diffusion behavior of unstimulated TNFR1 and TNFR2. HeLa cells were transiently
transfected with low levels of TNFR1Δ42-EGFP (A and C) or TNFR2-EGFP (A and B)
expression constructs. A. Typical autocorrelation curves obtained from TNFR1Δ42-EGFP
(□) and TNFR2-EGFP (○) FCS measurements. The curves were ﬁtted using a 2D-two-
component-function (black line) and corresponding residuals are shown in the bottom.
B and C. Histograms showing the distribution of diffusion coefﬁcients calculated from
137 (TNFR1Δ42-EGFP) and 85 (TNFR2-EGFP) individual autocorrelation curves,
respectively, typically derived from 20 cells with each ﬁve measurements performed
at different positions of the plasma membrane.
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cytosolic particles.
Each particle performed a random walk independently from the
other particles. The time steps of the simulationwere set toΔt=280 μs,
i.e., orders of magnitude smaller than the diffusion time of the
experiments. The distance between subsequent steps of a particle was
determined by a random variable with a Gaussian distribution with a
center value 0 and a standard deviation of SDmem =
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
4DmemΔt
p
where
Dmem is the diffusion coefﬁcient of the membrane receptors and
SDcyt =
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
6DcytΔt
p
whereDcyt is thediffusion coefﬁcient for the cytosolic
particles.
Shot noise of the signal and Poissonian distributed backgroundwas
considered, both chosen in the same order as found in experiments
(signal ∼2000 cps, background ∼1000 cps). The program was tested
for stability by varying parameters as follows: size of the membrane
fragment, diffusion constant D, dwell time Δt. The chosen parameters
reproduce the diffusion constant accurately.
There are two applications within this article where simulations
yield additional information: (i) the degree of oligomerization of TNFR
after stimulation can be extracted by comparison of the photon
counting histograms of themeasuredwith simulated data and (ii) cal-
culation of the pure stochastical error of a FCS measurement which is
not given by the ﬁtting procedure.
3. Results and discussion
3.1. Diffusion behavior of unstimulated TNFR1 and TNFR2
Confocal microscopy experiments using HeLa cells stably expressing
TNFR2, HeLa80, indicated that TNFR2 is homogeneously distributed on
the plasmamembrane in the absence of TNF, but forms aggregates after
stimulation [4]. In contrast, TNFR1 tends to form aggregates after
overexpression even in the absence of TNF, leading to the activation of
TNFR1 [35,36]. To avoid artifacts due to overexpressionwe investigated
the response of TNFR1 and TNFR2 by FCS at expression levels of
endogenously expressed receptors (between 300 and 3000 TNFR1
molecules and up to 10,000 TNFR2molecules per cell, data not shown).
Expressionof TNFR1-YFP inHeLa cells induced strong caspase activation
(data not shown). However, TNFR1-YFP could not be detected on the
cell surface by FACS and immunoﬂuorescence microscopy and thus did
not allow FCS measurements. Therefore, we used TNFR1Δ42-EGFP
where TNFR1 was truncated C-terminally by 42 aa. This molecule was
expressed at low but detectable levels on the cell surface. For FCS
measurements wild type HeLa cells were transiently transfected with
low amounts of the expression vectors pTNFR1-Δ42EGFP and pTNFR2-
EGFP, respectively, and diffusion coefﬁcients for these molecules were
calculated from FCS curves (Fig. 1). Since the measurements were done
at room temperature, cell viability was analyzed by annexin V-FITC/
propidium iodide staining after a mock experiment. Flow cytometry
analyses revealed a total of b5% positive cells (Fig. S1, supplemental
material) similar to control cells kept under cell culture conditions (data
not shown). Visual inspection of the TNFR2-EGFP autocorrelation curve
points to two different components, a very fast component of
approximately 10−7 cm2/s and a considerably slower component in
the order of 10−9 cm2/s. Due to its large value the fast component
cannot be assigned to diffusion processeswithin the plasmamembrane.
In fact, free diffusing species within the cytoplasm show diffusion
constants in the order of 10−7 cm2/s. As there was no respective
ﬂuorescence observed in non-transfected HeLa cells (data not shown),
free cytoplasmic EGFP produced from a second transcription initiation
signal or generated by proteolysis is a likely source of the fast
component. This is supported by Western Blot analysis of HeLa cells
expressing TNFR2-EGFP showing an additional fast migrating form
comigrating with free EGFP (see Fig. S2, supplemental material).
Estimations revealed the latter to be produced at levels of 10–30%
compared to the fusion protein. Therefore, all curves were ﬁtted with atwo-component model assuming two-dimensional diffusion for the
slower and three-dimensional diffusion for the fast component. For all
experiments the diffusion coefﬁcients corresponding to the fast
components were constant (∼2×10−7 cm2/s). The fast component
was therefore held ﬁxed in the following ﬁtting procedures. The other
three free ﬁtting parameters, namely G(0) of the fast and the slow
component, and the diffusion time of the slow component resulted in
adequate ﬁtting of the majority of data. An addition of further
parameters did not signiﬁcantly increase the ﬁt quality. Thus, we used
a ﬁtting scheme with the slower component referring to membrane-
integrated TNFR2-EGFP revealing amean value ofD
–
=3.1×10−9 cm2/s
and a width (twice the standard deviation, SD) of the distribution of
1.4×10−9 cm2/s (Fig. 1B; number ofmeasurements n=85). Thewidth
of the distribution is composed of the statistical error and differences in
the dynamics of TNFR2-EGFP at different positions within the plasma
membrane. To evaluate the statistical error of the distribution we
simulated the autocorrelation curve as this information cannot be
extracted from the ﬁtting procedure of the experimental data [34].
Simulations and ﬁttings of 20 traces using comparable parameters as
used in the experiment revealed a statistical error in the range of
ΔD=0.5×10−9 cm2/s (data not shown). In contrast we obtained
experimentally diffusion coefﬁcients over a range of 1.4×10−9 cm2/s
suggesting that a dynamic interaction between TNFR2-EGFP and other
cellular components, e.g. proteins and lipids, leading to hindered
diffusion might cause this phenomenon [37].
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1.2×10−9 cm2/s with a width of the distribution of 1.7×10−9 cm2/s;
n=137; Fig. 1A and C) differing signiﬁcantly from that of TNFR2-EGFP.
Whereas the average diffusion coefﬁcient is less than half of that
calculated for TNFR2-EGFP (D
–
=3.1×10−9 cm2/s), the histogram of
TNFR1Δ42-EGFP shows a rather broad range of diffusion coefﬁcients
with D-values as low as 10−10 cm2/s. Similar results were obtained
when TNFR1Δ42-EGFP was expressed in mouse ﬁbroblasts derived
fromTNFR1/TNFR2 double knockoutmice (D
–
=1.4×10−9 cm2/swith
a width of the distribution of 1.4×10−9 cm2/s; n=51; Fig. S3,
supplemental material). These results indicate that the slow mem-
brane diffusion of TNFR1Δ42-EGFP is not cell type speciﬁc. Again, the
autocorrelation curves were ﬁtted with a two-component model with
a constant fast component of approximately 2×10−7 cm2/s and a
slow component assigned to TNFR1Δ42-EGFP in the plasma mem-
brane. It is important to emphasize that successive measurements at
the same position of the membrane revealed similar results. Together,
these data indicate that the dynamics of TNFR1 and TNFR2 in the
plasma membrane are quite different.
3.2. Stimulation of TNF receptors by their ligand TNF
Soluble TNF (sTNF) forms stable homotrimers and is therefore
believed to bind more than one receptor as a ﬁrst step of receptor
activation [2,5]. TNFR1 can be fully activated by sTNF. TNFR2, how-
ever, is hardly activated by this form of the ligand [16]. Accordingly,
the membrane-integrated precursor form of TNF, memTNF, repre-
sents the naturally occurring activating ligand for this receptor [16].
For efﬁcient stimulation of TNFR2, we used CysTNF mimicking
membrane bound TNF by the formation of oligomers due to N-
terminal introduced Cysteine residues [17]. The introduction of two
point mutations (CysTNF143N/145R) resulted in a TNFR2-selective
activator [4,38].
Stimulation of TNFR1Δ42-EGFP with near to saturating concentra-
tions of sTNF (100 ng/ml), i.e. the 20-fold concentration of that deter-
mined for the dissociation constant in equilibrium binding studies [39],
resulted in no signiﬁcant changes in the distribution of D-values within
60 min (D
–
stimulated=1.1×10−9 cm2/s; n=101; Fig. 2A and Table 1). In
contrast, a considerable reduction in the diffusion time of up to one
order of magnitude within 30 min was observed for stimulated TNFR2-
EGFP using CysTNF143N/145R, in the following referred to as CysTNFR2
(100 ng/ml) (Fig. 2B–DandTable 1). Thiswas typical for all investigated
cells at all positions of the plasmamembrane. Although the distribution
of D-values became relatively broad 30 min after stimulation with
CysTNFR2 (Fig. 2B, hatched bars), a signiﬁcant shift of the distribution
fromameanvalueofD
–
=3.1×10−9 cm2/s toD
–
=0.9×10−9 cm2/swas
observed (Fig. 2B; n=96). These results could be conﬁrmed in
experiments using mouse ﬁbroblasts showing a mean of the diffusion
coefﬁcient of D
–
=2.9×10−9 cm2/s before and D
–
=0.9×10−9 cm2/s
after stimulation with CysTNFR2, again indicating that the results are
independent of the cell line (Fig. S4B, supplemental material).
Since TRAF2 is recruited to the cytoplasmic part of TNFR2 after
receptor activation, efﬁcient activation of this receptor should affect
the diffusion behavior of TRAF2. Investigation of HeLa80 cells tran-
siently expressing TRAF2-EGFP revealed two TRAF2 populations
in unstimulated cells, one residing close to the plasma membrane
(D
–
=0.3×10−7 cm2/s; n=22; Fig. S5, supplementarymaterial, crossed
bars), and another one in the cytoplasm (D
–
=2.6×10−7 cm2/s, n=30
Fig. S5, supplementary material, gray bars). This effect is likely to be
caused by interactions of TRAF2 with plasma membrane (associated)
components, such as TNFR2 itself caused by high level expression in
HeLa80 cells (approximately 30,000 TNF/TNFR2 binding sites; data not
shown) and/or caveolin-1 [7]. Importantly, after stimulation with
TNFR2-selective CysTNFR2 the mean value of the diffusion coefﬁcient of
TRAF2 near the plasma membrane decreased further by one order of
magnitude (D
–
=2.7×10−9 cm2/s; n=44; Fig. S5, supplementarymaterial, hatched bars) caused most likely by binding of TRAF2 to the
TNFR2-EGFP signaling complex. Thedifference between thedynamics of
TRAF2 and that of TNFR2-EGFP after stimulation (D
–
=0.9×10−9 cm2/s,
Fig. 2B, hatched bars) results probably from the presence of additional
TRAF2-EGFP molecules not bound to TNFR2 that give rise to a second,
unresolvable component in the correlation function.
To exclude that a change in plasmamembrane viscosity is the reason
for the observed reduction in the diffusion of TNFR2 and TRAF2 after
stimulation, we determined the diffusion coefﬁcient of a rhodamine
labeled phosphatidylethanolamine (PE). No signiﬁcant change in the
overall viscosity of the plasmamembranewas detected before and after
stimulation of TNFR2-EGFP with CysTNFR2 (data not shown).
3.3. Time evolution of TNFR2 diffusion
To obtain the evolution of the diffusion coefﬁcient of activated
TNFR2-EGFP as a function of time, an autocorrelation curve of TNFR2-
EGFP in HeLa and HeLa80 cells expressing wild type TNFR2 ad-
ditionally to transiently transfected TNFR2-EGFP expression con-
structs were measured every 2 min over a time period of 1 h.
Immediately after stimulation the diffusion coefﬁcient started to
decrease until it reached its minimum value approximately 30 min
after stimulation (Fig. 2C and D). This was followed by a recovery of
the diffusion coefﬁcient until it reached the initial value after 50 min.
Recovery is unlikely to be caused by reappearance of unligated
receptors after receptor mediated CysTNFR2 depletion or CysTNFR2
degradation, because the ligand is present in an at least hundred fold
excess and is very stable under cell culture conditions (data not
shown). Both TNF receptors are known to activate NF-κB within about
ﬁve to ten minutes showing maximum activation after about 30 to
60 min [4]. In accordance with these data, signiﬁcant TRADD (TNF
receptor 1-associated death domain-containing protein) recruitment
to TNFR1 can be observed already 5 min after stimulation [40] and
TRAF2 recruitment to TNFR2 after 10 min, respectively [4]. The
formation of functional signaling complexes, therefore, parallelizes
changes in the diffusion of TNFR2-EGFP (Fig. 2B–D).
Our data clearly show an overall decrease in the diffusion coefﬁcient
of TNFR2 over the ﬁrst 35 min after ligand addition. Thereafter, long
diffusion times vanish and molecules with short diffusion times
reappear during experiments (Fig. 2D). The decline in the diffusion
coefﬁcients immediately after stimulation of TNFR2 could be explained
by several different models being discussed in detail below. Further-
more, the disappearance of the long diffusion times could easily be
explained by internalization of ligand/receptor complexes within 30–
45min after stimulation as revealed from studies with cells over-
expressing TNFR2 [15]. However, the reappearance of molecules with
short diffusion times during experiments was unexpected (Fig. 2D).
Note that the ligand CysTNFR2 was not removed or depleted after
stimulation of the cells so that newly expressed TNFR or recycled TNFR
should bind TNF readily after its appearance on the cell surface.
Accordingly, our results indicate a fraction of TNFR2 molecules
reappearing that is either not capable to bind CysTNFR2 or which
diffuses identical to unstimulated TNFR2 after ligand binding. Possible
explanations for the existence of this particular behavior are: (i) a
concentration dependent equilibration between pre-associated and
monomeric receptors, and/or (ii) two different kinds of pre-associated
receptors and/or (iii) receptor processing.
To (i): There is strong evidence that TNFR2 exists in a pre-
associated form in the plasma membrane [41], which is likely to be
concentration dependent. As only pre-associated receptors are ca-
pable to stably bind the ligand [41], form receptor signaling
complexes and are internalized, the residual (monomeric) receptor
fraction might be too small to allow re-association, especially if
kinetics of receptor association on the cell surface is slow. Under these
conditions monomeric receptors could still be visible in FCS, but
would not be further activated by the presence of CysTNFR2. This
Fig. 2. Time evolution of TNF receptor diffusion after ligand stimulation. HeLa cells (A, B and D) and HeLa cells stably expressing TNFR2 (HeLa80; C) were transiently transfected with
pTNFR1Δ42-EGFP and pTNFR2-EGFP, respectively. Cells were stimulated by the addition of 100 ng/ml sTNF (A) or TNFR2-selective CysTNFR2 (B–D). The diffusion coefﬁcients were
calculated from the autocorrelation curves generated from the FCS measurements. A. Distribution of diffusion coefﬁcients for TNFR1Δ42-EGFP before (gray bars) and 60 min after
stimulation (hatched bars). B. Distribution of diffusion coefﬁcients for TNFR2-EGFP before (gray bars) and 30 min after stimulation (hatched bars). C. Correlation functions before
stimulation (□), 10 min (Δ). 20 min (○) and 30 min (◊) after stimulation. The solid lines represent ﬁt functions using the 2D-diffusion model. (D) Diffusion constants D obtained by
FCS as a function of time t [min] after stimulation. FCS measurements were performed every 2 min at the same spot of the plasma membrane of a single cell.
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which are anti-proportional to the receptor number within the focal
volume. The amplitudes of the curves measured after 50 min are
indeed larger than those at the beginning of the experiments, i.e. the
concentration of TNFR2 after 50 min is smaller than before stimula-
tion (data not shown). However, bleaching of the backgroundTable 1
Average diffusion constants of TNFR1- and TNFR2-derived EGFP fusion proteins and TRAF2. D
–
receptor stimulation and D
–
w/o_cholesterol average diffusion constants of unstimulated recept
individual measurements. In average 5 measurements were performed on a single cell and
were carried out with HeLa cells except the control measurement carried out in mouse ﬁbrob
to the membrane (mem, row 8).
Receptor D
–
[cm2/s] SD [cm2/s] # Exp D
–
stim [c
TNFR1Δ42-EGFP 1.2×10−9 0.9×10−9 137 1.1×10
TNFR1Δ42-EGFP (mouse ﬁbroblasts) 1.4×10−9 0.6×10−9 51 –
TNFR2 3.1×10−9 0.7×10−9 85 0.9×10
TNFR2 (mouse ﬁbroblasts) 2.9×10−9 0.7×10−9 30 0.9×10
TNFR2 (cytochalasin D treated) 2.3×10−9 0.7×10−9 24 1.0×10
TNFR1-ΔSD 1.2×10−9 0.9×10−9 72 1.2×10
TNFR2-ΔSD 2.9×10−9 0.7×10−9 151 1.1×10
TRAF2 (cyt) 2.6×10−7 0.2×10−7 30 –
TRAF2 (mem) 3.1×10−8 1.5×10−8 22 2.7×10ﬂuorescence affects similarly the amplitude of the autocorrelation
curve.
To (ii): Pre-association of the TNFR should occur non-covalently.
However, TNF receptors and also the related receptors CD40 and Fas
have been described to form covalently linked homodimers/trimers.
These molecules can be observed even on the cell surface of cultured, average diffusion constants before receptor stimulation, D
–
stim, diffusion constants after
ors after cholesterol depletion. SD is the standard deviation and # Exp the number of
the data present the mean of at least three independent transfections. All experiments
lasts (row 3). TRAF2 experiments were carried out in the cytosol (cyt, row 7) and close
m2/s] SD [cm2/s] # Exp D
–
w/o_cholesterol [cm2/s] SD [cm2/s] # Exp
−9 0.8×10−9 101 2.0×10−9 0.8×10−9 51
– – – – –
−9 0.6×10−9 96 3.0×10−9 0.7×10−9 51
−9 0.6×10−9 30 – – –
−9 1.0×10−9 34 – – –
−9 0.8×10−9 31 – – –
−9 0.6×10−9 208 – – –
– – – – –
−9 2.2×10−9 44 – – –
Fig. 3. Diffusion behavior of TNF receptors with truncated intracellular domains.
A. Distribution of the diffusion coefﬁcient of TNFR1ΔSD-EGFP (aa 1–235) before (gray
bars) and 30 min after stimulation (hatched bars) with sTNF (100 ng/ml).
B. Distribution of the diffusion coefﬁcient of TNFR2ΔSD-EGFP (aa 1–300) before (gray
bars) and 30 min after stimulation (hatched bars) with CysTNFR2 (100 ng/ml). All data
were obtained from measurements using transiently transfected HeLa cells.
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covalently bound dimers are still unknown. It can be therefore
speculated that these homodimers form a separate receptor subpop-
ulation with different behavior, e.g. without the capability to associate
to specialized membrane compartments. In this scenario ligand
binding could result in a fast diffusion within the membrane as it
has been found after 50 min in the experiment.
To (iii): TNFR2 is known to be a substrate of metalloproteinases,
which remove the ectodomain of the molecule resulting in the
production of soluble TNFR2. This process is stimulus dependent and
known to be triggered to some extend by TNF itself [44]. The residual
membrane anchored cytoplasmic part, still EGFP tagged in our
experiments, would then diffuse freely in the membrane, unaffected
by the ligand.
3.4. Dynamics of TNFR is independent of their signaling domains
During the last decade it became apparent that the actin-based
membrane cytoskeleton is mainly responsible for a reduced diffusion
of lipids and membrane proteins in cells when compared to that in
artiﬁcial lipid bilayers. High time resolution single particle tracking
indicates that different hierarchies of compartments might exist in
membranes and that lipids and transmembrane proteins are conﬁned
in compartments of hundreds of nm being comprised in larger
probably micron sized structures [45–47]. These compartments are
due to pinning of transmembrane proteins along the actin cytoskel-
eton circumventing the hopping between these compartments [48]. A
similar behavior was also observed for the transferrin receptor using
FCS [49].
Due to ahierarchical structureof the compartments it is possible that
unstimulated TNFR diffuses freely although being conﬁned to a small
compartment not observable by standard FCS measurement. After
stimulation, however, interactions of TNFR signaling complexes with
parts of the cytoskeleton of higher hierarchy could lead to a marked
reduced diffusion. To investigate whether speciﬁc interactions via the
cytoplasmic parts of the receptorswith the cytoskeleton are responsible
for the observed reduced diffusion rates, we constructed deletion
mutants of TNFR1 and TNFR2 lacking their respective signaling domains
and fused them to EGFP. Deletion of the complete signaling region of
TNFR1 (TNFR1ΔSD-EGFP) showed no increase in the diffusion constant
for both TNF treated and untreated TNFR1ΔSD-EGFP (Fig. 3A). Again a
broad distribution of D-values was found comparable to TNFR1Δ42-
EGFP (Fig. 1C) showing a mean value of D
–
=1.2×10−9 cm2/s for
TNFR1ΔSD-EGFP before stimulation (n=72) and D
–
=1.2×10−9 cm2/s
after stimulation (n=31).
In the case of TNFR2-EGFP, the cytoplasmic domain of the re-
ceptor was fully truncated except for 14 aa and then fused to EGFP
(TNFR2ΔSD-EGFP). Again, FCS studies revealed nomajor changes in the
diffusion behavior caused by this deletion (D
–
=2.9×10−9 cm2/s;
n=151 vs. D
–
=3.1×10−9 cm2/s for the respective wild type mol-
ecules; Fig. 3B and Table 1). Moreover, a reduction of the diffusion of
TNFR2ΔSD-EGFP by approximately a factor of ﬁve was observed after
stimulation with CysTNFR2 (D
–
=1.1×10−9 cm2/s; n=208; Fig. 3B),
similar to wild type receptor derived TNFR2-EGFP (Fig. 2B). These data
show that the respective (in TNFR1Δ42-EGFP partially truncated)
cytoplasmic parts are not responsible for their particular diffusion
behavior.
In further experiments, disruption of actin ﬁlaments of the cyto-
skeleton by cytochalasin D treatment did not result in an increase of the
diffusion coefﬁcients for unstimulated as well as for stimulated full
lengthTNFR2-EGFP (Fig. S4A, supplementalmaterial andTable1). These
data demonstrate that efﬁcient actin depolymerisation, as observed by
staining with phalloidin (data not shown), does not affect TNFR2-EGFP
diffusion. Interestingly, interactions of ezrin with the 14 membrane-
proximal amino acids of CD95/Fas, which links this receptor to the actin
cytoskeleton has been demonstrated recently [50]. Based on sequencesimilarities in this region, present also in TNFR2ΔSD-EGFP, TNFR2 has
been discussed by the same authors to possibly recruit ezrin. Actin
depolymerisation may not necessarily result in TNFR2 release from
ezrin containing membrane complexes. Accordingly, ligand induced
binding to complexed ezrin would be one possibility to explain the
reduction in TNFR2 diffusion after stimulation (Fig. 2B).
3.5. Evaluation of the receptor aggregates ﬂuorescence intensity
Confocal ﬂuorescencemicroscopy on HeLa80 cells shows large TNF/
TNFR2 aggregates on the cell surface after stimulation [4]. The formation
of larger receptor complexes appears feasible as TNF formshomotrimers
with three TNFRbinding sites. Additionally, there is convincing evidence
that the receptors exist in apre-associated form(homodimer or -trimer)
in the plasma membrane [41]. Such ligand/receptor complexes could
form large aggregates as already proposed [51] and could explain the
decrease of the diffusion coefﬁcient after TNFR2 stimulation in our
experiments (Fig. 2B, C and D). However, more than 1000 receptors
would be required to explain this phenomenon solely by the increased
cluster size [52]. Such aggregates should be identiﬁed easily from
ﬂuorescence traces of labeled TNFR when working at the single
molecule level. Comparison of traces recorded at the same position
within the plasma membrane of wild type HeLa cells transiently
expressing TNFR2-EGFP at low levels before and 20 min after TNFR2
stimulation revealed no major increase in the maximal ﬂuorescence
intensities after stimulation (Fig. 4A and B), although the diffusion
coefﬁcient decreased (data not shown). Data of the same experiment
were analyzed using the photon counting histogram (PCH), in order to
reveal any statistically signiﬁcant change in thebrightness. In contrast to
the expected increase of a factor of 1000, there were only very slight
differencesbetween thePCHbefore (black crosses) andafter (red crosses)
Fig. 4. Evaluation of TNFR2-EGFP ﬂuorescence intensity after stimulation. A and B. Typical
examples of ﬂuorescence ﬂuctuations of TNFR2-EGFP before (A) and 20 min after
stimulation (B) with CysTNFR2 (100 ng/ml) in HeLa cells transiently transfected with
pTNFR2-EGFP. Every spike in the trace represents a single entity. C. Photon counting
histograms of TNFR2-EGFP before (black crosses), after stimulation (red crosses),
simulated monomer (blue), simulated dimer (green) and trimer (orange). Simulations
have been performed as described in Materials and methods.
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for brightness per particle, background, and diffusion constant as found
in the experiments. Fig. 4C shows the results for a TNFR2 monomer
(blue), a dimer (green), and a trimer (orange). It is obvious that the PCH
for count rates less than 1500 are governed by the background. For
higher count rates the degree of oligomerization is the dominant factor.
The maximum count rates scale approximately with the number of
chromophores per diffusing particle starting at approximately 2000
counts for the monomer and increasing to ∼6000 counts for the trimer.
The PCH analyses of unstimulated TNFR2 correspond to the simulated
PCH of themonomer. The PCH analysis of stimulated TNFR2 shows only
a slightly higher maximum count rate than unstimulated receptors, i.e.
in between the values of themonomer and the dimer. As TNF has three
receptor binding sites, TNFR2 intensities at least three times larger in the
maximum count rate could be expected after stimulation. However, as
receptor pre-association in the absence of a ligand has been previously
demonstrated [41], a pre-dimerization/-trimerization of unstimulated
TNFR2 as actual TNF binding partner would easily explain the lack of
higher intensities after stimulation. Together, these data argue against
the formation of large TNF/TNFR2 aggregates after stimulation,
although this could have easily explained the drastic reduction in
TNFR2 diffusion. Rather, our results suggest the formation of an active
TNFR2 signaling complex consisting of only few TNFR2molecules at this
low expression level.
3.6. Cholesterol depletion affects the dynamics of TNFR1 but not that of
TNFR2
Important factors inﬂuencing the diffusion of a transmembrane
protein are membrane composition and microstructure [53]. Thephysical nature of membrane microdomains is currently a matter of
intense discussion [54–56]. The most intensely discussed type of a
microdomain is described as small, heterogeneous, highly dynamic,
sterol- and sphingolipid-enriched domain that is formed by lipid–
lipid interactions that compartmentalize cellular processes. Small
microdomains of this type can be stabilized to form larger platforms
through protein–protein and protein–lipid interactions [57]. These
microdomains are not resolvable by conventional optical FCS. Data
have been published suggesting that TNFR1 is associated with
membrane microdomains [6,7,12,58]. Biochemical studies have
delineated distinct roles for lipid microdomains in TNFR signaling
[8]. Although the results presented might be partly dependent on the
respective cell type, there is some evidence that TNFR1 translocates
intomicrodomains withinminutes after ligand binding facilitating the
recruitment of adapter proteins such as RIP (receptor interacting
protein), TRADD and TRAF2 [6,7,58]. Disruption of microdomains by
cholesterol depletion has been shown to inhibit NF-κB activation [7].
To investigate whether the diffusion of the two TNFR is affected by the
lipid composition of the membrane we depleted cholesterol from the
plasma membrane by methyl-β-cyclodextrine (MβCD) treatment. A
moderate, but signiﬁcant effect on TNFR1Δ42-EGFP diffusion was
observed, i.e. an increase of the mean value of the diffusion coefﬁcient
from D
–
=1.2×10−9 cm2/s to D
–
=1.6×10−9 cm2/s (40 min after
MβCD treatment) and D
–
=2.0×10−9 cm2/s (120 min after MβCD
treatment, Fig. 5A). A stimulation of MβCD pretreated HeLa cells with
TNF revealed no further changes in the observed diffusion behavior
(data not shown). Similar experiments with TNFR2-EGFP, either
untreated (Fig. 5B) or pretreated with MβCD (Fig. 5C), with
CysTNF143N145R revealed no detectable changes in the respective
diffusion coefﬁcients (Table 1). These data strongly suggest that
TNFR1Δ42-EGFP, but not TNFR2-EGFP, is located in membrane
microcompartments rich in cholesterol.
4. Conclusion
This study provides insights into the diffusion dynamics of TNF
receptors under physiological conditions before and after ligand
stimulation. Although structurally very similar in their transmembrane
and extracellular domains both receptors show markedly different
behaviors. Unstimulated TNFR2-EGFP shows a narrow distribution of
diffusion constants, revealing no changes upon reduction of the
cholesterol content in the membrane. The drastic reduction of the
diffusion constant after receptor stimulation cannot be explained by the
formation of large receptor clusters observed in overexpression systems
[4], because ﬂuorescence intensity traces point to the presence of
aggregates containing a very small number of TNFR2-EGFP molecules
only. Recruitment of known interaction partners and signaling adapters
are also unlikely to cause the reduced dynamics of stimulated TNFR2-
EGFP as deletion of the signaling domain shows no effects on diffusion.
Furthermore, and in contrast to TNFR1Δ42-EGFP, our data give no
evidence for an association of TNFR2-EGFP to cholesterol rich domains.
We therefore suggest that small TNFR2 aggregates are trapped at/
within speciﬁc cholesterol independent membrane compartments/
interaction partners after stimulation. As described for CD95/Fas, ezrin
is a possible candidate, known to be involved in actinﬁlament linkage to
the membrane [50].
In contrast to TNFR2, TNFR1Δ42-EGFP shows a much slower dif-
fusion constant as well as a broader distribution of diffusion constants
independent of its stimulation. However, the diffusion constant of
TNFR1Δ42-EGFP depends on the cholesterol content of the plasma
membrane. Most notably the slowest fraction of TNFR1Δ42-EGFP
disappears upon reduction of the cholesterol level of the membrane.
In linewith previouswork onwild type TNFR1 our experiments suggest
that a large fraction of TNFR1Δ42-EGFP is located in membrane
microdomainswhich become disintegrated upon cholesterol depletion.
Cholesterol richmicrodomains like caveolae are possible sites for TNFR1
Fig. 5. Effects of cholesterol depletion on the dynamics of TNFR diffusion. Distribution of
the diffusion coefﬁcients of TNFR1Δ42-EGFP (A) and TNFR2-EGFP (B and C),
respectively, transiently expressed in HeLa cells. A. Cells were left untreated (red
bars) or had been pretreated with 1 mM MβCD for 40 min (green bars) or 120 min
(blue bars). About 100 measurements for each data set were recorded at different
positions of the plasma membrane of more than 25 cells. B. Cells were left unstimulated
(red bars) or were stimulated with CysTNFR2 (100 ng/ml) for 30 min. C. HeLa cells
transiently expressing TNFR2-EGFP had been pretreated with 1 mM MβCD for 30 min
and FCS measurements were performed immediately after (red bars) or upon
stimulation with CysTNFR2 (100 ng/ml) for 30 min.
1088 M. Gerken et al. / Biochimica et Biophysica Acta 1798 (2010) 1081–1089trapping [59]. Altogether, our results allow two important hypotheses.
First, they strongly argue for a distinct compartmentalization of the two
TNF receptors in the plasma membrane, which might be the major
reason why no heteromeric ligand/receptor complexes have been
described so far although we explicitly enquired their existence [60].
Second, they argue that this differential compartimentalization is most
likely determined by the respective transmembrane domains and/or
transmembrane domain near region(s), because TNF receptor con-
structs lacking the capability to interact with any known cytoplasmic
signaling partners still showed the same diffusion behavior.Acknowledgement
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